Skip to main content
天润科技 logo

天润科技 — Investor Relations & Filings

Ticker · 920564 Beijing Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 446 across all filing types
Latest filing 2023-11-02 Regulatory Filings
Country CN China
Listing Beijing Stock Exchange 920564

About 天润科技

https://www.trgis.com/

Tianrun Technology provides comprehensive geospatial information services, specializing in high-precision surveying, mapping, and remote sensing. The company utilizes advanced photogrammetry and satellite data processing to create detailed spatial datasets and 3D digital twins. Its core service portfolio includes the development of Geographic Information Systems (GIS) and smart city platforms designed for urban planning, natural resource management, and environmental monitoring. By integrating multi-source data acquisition with sophisticated spatial analysis, the company delivers technical solutions for spatial data infrastructure and digital transformation. Its expertise extends to aerial photography and the creation of high-accuracy models that support infrastructure management and informed decision-making processes.

Recent filings

Filing Released Lang Actions
上海荣正企业咨询服务（集团）股份有限公司关于陕西天润科技股份有限公司2022年股权激励计划第一个解除限售期解除限售条件及第一个行权期行权条件成就之独立财务顾问报告
Regulatory Filings Classification · 95% confidence The document is titled as an "Independent Financial Advisor Report" regarding the 2022 equity incentive plan of Shaanxi Tianrun Technology Co., Ltd. It discusses the achievement of the first restricted stock lifting period and the first stock option exercise period conditions. The content includes detailed explanations of the equity incentive plan, approval procedures, performance conditions, and specific stock option and restricted stock details. It references regulatory frameworks such as the Company Law, Securities Law, and specific stock exchange rules. The document is a detailed advisory report by an independent financial consultant on the equity incentive plan's progress and compliance, not a general annual or quarterly financial report, nor a simple announcement. It is not a proxy statement, voting result, or remuneration report. It is a specialized advisory report related to equity incentive plans and their conditions. This fits best under the category of Regulatory Filings (RNS) as it is a regulatory disclosure document that does not fit into other specific categories like Annual Report, Earnings Release, or Management Reports. The document length (over 14,000 characters) and detailed content confirm it is not a mere announcement but a full advisory report. Therefore, the classification is Regulatory Filings (RNS) with high confidence.
2023-11-02 Chinese
关于2022年股权激励计划第一个解除限售期解除限售条件及第一个行权期行权条件成就的公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement from a company regarding the achievement of conditions for the first unlocking period of a 2022 equity incentive plan and the first exercise period of stock options. It includes detailed information about board and supervisory approvals, performance conditions, individual assessments, and specific numbers of shares and options involved. The document is not a full annual or interim financial report, nor is it a simple announcement of a report. It is not a transcript, nor a legal proceeding update, nor a capital financing update. It is a regulatory announcement about equity incentive plan conditions being met and related share unlocking and option exercising. This type of document fits best under the category of Regulatory Filings (RNS) as it is a regulatory disclosure about equity incentive plan progress and conditions met, not a full report or a proxy solicitation or remuneration report. The document length and detail confirm it is not a brief announcement or a report publication announcement.
2023-11-02 Chinese
第四届监事会第十五次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement of resolutions passed at the 15th meeting of the 4th Supervisory Board of Shaanxi Tianrun Technology Co., Ltd. It details meeting attendance, agenda items, voting results, and compliance with relevant laws and company regulations. The content focuses on supervisory board decisions regarding stock option cancellations, adjustments, and conditions for lifting restrictions, without presenting financial statements or detailed financial analysis. It is a regulatory announcement about board-level decisions rather than a full management report or financial report. The document length is short (1833 characters), and it is an official meeting resolution announcement, not a full report or presentation. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2023-11-02 Chinese
监事会关于2022年股权激励计划第一个解除限售期解除限售条件及第一个行权期行权条件成就等相关事项的核查意见
Board/Management Information Classification · 95% confidence The document is an official announcement from the Supervisory Board regarding the verification and opinions on the company's 2022 equity incentive plan, including stock option cancellations, adjustments to exercise prices, and conditions for lifting restrictions and exercising options. It references regulatory guidelines and internal company plans but does not contain financial statements or detailed financial performance data. The document is a formal verification and opinion statement related to management decisions on equity incentives, which aligns with announcements about management or board-related information rather than a full report or financial release. Therefore, it fits best under Board/Management Information (MANG). The document length is short and focused on governance and management decisions about stock incentives, not a full report or regulatory filing.
2023-11-02 Chinese
北京市尚衡（西安）律师事务所关于陕西天润科技股份有限公司2022年股权激励计划第一个解除限售期解除限售条件及第一个行权期行权条件成就之法律意见书
Regulatory Filings Classification · 75% confidence The document is a legal opinion letter issued by an external law firm (法律意见书) confirming that the conditions for the first restricted‐stock unlocking period and the first option exercise period under the company’s 2022 equity incentive plan have been met. It does not contain financial statements or serve as the primary company report, nor is it announcing board changes, dividends, M&A, or an earnings release. Instead, it is a compliance letter filed with the exchange to satisfy regulatory disclosure requirements. Therefore, it falls into the fallback category “Regulatory Filings (RNS).”
2023-11-02 Chinese
关于调整2022年股权激励计划股票期权行权价格的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the adjustment of the stock option exercise price under the company's 2022 equity incentive plan. It details board and supervisory meetings, approvals, and legal opinions related to the adjustment. The document is relatively short (3265 characters) and focuses on a specific corporate action related to stock options and equity incentives. It does not contain comprehensive financial statements or detailed financial performance data. It is not a full annual or interim report, nor is it a call transcript or earnings release. The content fits best with a Capital/Financing Update (CAP) as it relates to changes in stock option exercise prices, which affect the company's capital structure and equity incentives.
2023-11-02 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.